Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    Elsamitrucin
Show Display Options
Rank Status Study
1 Completed Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: Mantle Cell Lymphoma;   Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Intervention: Drug: Elsamitrucin
2 Completed Elsamitrucin (SPP 28090) in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma
Intervention: Drug: Elsamitrusin

Study has passed its completion date and status has not been verified in more than two years.